Efficacy of pregabalin therapy for patients with oral cancer in terminal stage

DOI 13 References
  • KANEKO RYUJI
    Department of Oral & Maxillofacial Surgery, Toyota Kosei Hospital
  • KAWAGUCHI TAKURO
    Department of Oral & Maxillofacial Surgery, Toyota Kosei Hospital
  • TOYA TOUGO
    Department of Oral & Maxillofacial Surgery, Toyota Kosei Hospital
  • OKABE KAZUTO
    Department of Oral & Maxillofacial Surgery, Toyota Kosei Hospital
  • UEDA MINORU
    Department of Oral & Maxillofacial Surgery, Nagoya University Graduate School of Medicine

Bibliographic Information

Other Title
  • ターミナルステージの口腔癌に対するプレガバリンの鎮痛効果に関する検討

Search this article

Abstract

We have often experienced the uncontrollable situation for cancer pain, especially peripheral pain such as numb, burning, and tingling even if using NSAIDs and/or opioids. It is recommended for such neuropathic pain to use some adjuvant analgesics. Pregabalin was approved for treatment of peripheral neuropathic pain besides postherpetic neuralgia and diabetic peripheral neuropathy in 2010. We started to use the medicine for oral cancer patients accompanied with peripheral neuropathic pain. In this study we investigated the efficacy of pregabalin as additional therapy on each characteristics of cancer pain. We have experienced 6 cases with oral cancer in terminal stage using the medicine. In almost all cases, pain was reduced at the end of the observation period. We were able to gain a good management of peripheral pain treated with pregabalin.

Journal

References(13)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top